Board approves preferential issue of 16.02 lakh shares at Rs 280 each

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹268.60

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+1.6% vs market

Pharmaceuticals peers, median of 175sector+0.0%+2.0% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0+0.4+1.6+0.0+2.0

Next day

+3.5-0.2+3.7-0.6+4.1

+6.1+0.3+5.8-0.2+6.3

+8.2+0.6+7.6-0.2+8.4

+10.3+0.8+9.5-0.4+10.8

+12.5+0.4+12.2-0.7+13.3

+17.1+0.7+16.3-0.6+17.7

15d

+24.1+2.0+22.1+1.6+22.5

+31.6+0.7+30.8+1.7+29.9

+79.5-3.4+82.8-4.2+83.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aptus Pharma's board approved issuing 16,02,870 equity shares on a preferential basis at Rs 280 per share (face value Rs 10), raising about Rs 44.88 crore from 190 allottees. Price was set based on a registered valuer's report with August 14, 2026 as the relevant date. The 16th AGM was scheduled for September 14, 2026 via video conferencing.

Likely market impact

Raises about Rs 44.88 crore from 190 investors at Rs 280 per share. Will dilute existing shareholders' stakes.